{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:24:24Z","timestamp":1773300264874,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.rcsop.2023.100385","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:46:34Z","timestamp":1701175594000},"page":"100385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["\u201cIt's just like putting your socks on\u201d: patients' perspectives on inflammatory bowel disease medication adherence"],"prefix":"10.1016","volume":"12","author":[{"given":"Obreniokibo Ibifubara","family":"Amiesimaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Aluzaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon","family":"Braund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2023.100385_bb0005","author":"Gastroenterological Society of Australia (GESA)"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100385_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100385_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2023.100385_bb0020","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"World Health Organisation (WHO)","year":"2003"},{"key":"10.1016\/j.rcsop.2023.100385_bb0025","article-title":"Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand","volume":"360","author":"Aluzaite","year":"2021","journal-title":"Crohns Colitis"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100385_bb0030","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/MIB.0b013e31829ed8a6","article-title":"Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease","volume":"19","author":"Selinger","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.rcsop.2023.100385_bb0035","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/MIB.0000000000001201","article-title":"Clinical predictors of future nonadherence in inflammatory bowel disease","volume":"23","author":"Severs","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rcsop.2023.100385_bb0040","author":"Kahui"},{"issue":"1574","key":"10.1016\/j.rcsop.2023.100385_bb0045","first-page":"82","article-title":"Constraints on medication-based inflammatory bowel disease therapy in Aotearoa New Zealand - why medication adherence is important","volume":"136","author":"Amiesimaka","year":"2023","journal-title":"N Z Med J"},{"issue":"suppl 1","key":"10.1016\/j.rcsop.2023.100385_bb0050","article-title":"An evidence-based systematic review on medical therapies for inflammatory bowel disease","volume":"106","author":"Talley","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100385_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/1744666X.2022.2069562","article-title":"Emerging therapies for ulcerative colitis","volume":"18","author":"Hanzel","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100385_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tips.2016.10.014","article-title":"Novel targeted therapies for inflammatory bowel disease","volume":"38","author":"Coskun","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100385_bb0065","first-page":"495","article-title":"Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: a systematic review","volume":"44","author":"Khan","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100385_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5217\/ir.2017.15.4.434","article-title":"Medication adherence in inflammatory bowel disease","volume":"15","author":"Chan","year":"2017","journal-title":"Intest Res"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100385_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12968\/gasn.2019.17.6.24","article-title":"Adherence in inflammatory bowel disease (IBD): a clinical review","volume":"17","author":"Bager","year":"2019","journal-title":"Gastrointest Nurs"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100385_bb0080","first-page":"1000106","article-title":"Educational Needs of Patients with Inflammatory Bowel Disease (IBD) and Nonadherence to Medical Therapy: A Qualitative Study","volume":"1","author":"Wheat","year":"2016","journal-title":"J Inflam Bowel Dis & Disord"},{"key":"10.1016\/j.rcsop.2023.100385_bb0085","series-title":"MoH","article-title":"Overview of the health system","author":"Manat\u016b Hauora \u2013 Ministry of Health (MoH)","year":"2023"},{"key":"10.1016\/j.rcsop.2023.100385_bb0090","series-title":"MedSafe NZ","article-title":"About Medsafe","author":"New Zealand Medicines and Medical Devices Safety Authority (MedSafe NZ)","year":"2023"},{"key":"10.1016\/j.rcsop.2023.100385_bb0095","author":"Pharmaceutical Management Agency (PHARMAC)"},{"key":"10.1016\/j.rcsop.2023.100385_bb0100","series-title":"Ministry of Health","article-title":"Prescription subsidy scheme","author":"Ministry of Health","year":"2022"},{"key":"10.1016\/j.rcsop.2023.100385_bb0105","series-title":"Subsidy for Adalimumab (PHARMAC)","author":"Application for Special Authority","year":"2020"},{"key":"10.1016\/j.rcsop.2023.100385_bb0110","series-title":"Budesonide (PHARMAC)","author":"Application for Subsidy by Special Authority","year":"2020"},{"key":"10.1016\/j.rcsop.2023.100385_bb0115","series-title":"PHARMAC","article-title":"Pharmaceutical schedule","author":"Pharmaceutical Management Agency (PHARMAC)","year":"2022"},{"key":"10.1016\/j.rcsop.2023.100385_bb0120","series-title":"Ministry of Health","article-title":"Pharmaceutical co-payments","author":"Ministry of Health (MoH)","year":"2014"},{"key":"10.1016\/j.rcsop.2023.100385_bb0125","series-title":"MoH","article-title":"Prescription charges and the prescription subsidy scheme","author":"Ministry of Health (MoH)","year":"2023"},{"key":"10.1016\/j.rcsop.2023.100385_bb0130","series-title":"Introducing Qualitative Research in Psychology","author":"Willig","year":"2008"},{"key":"10.1016\/j.rcsop.2023.100385_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-7-20","article-title":"Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study","volume":"7","author":"Hall","year":"2007","journal-title":"BMC Gastroenterol."},{"issue":"1536","key":"10.1016\/j.rcsop.2023.100385_bb0140","first-page":"25","article-title":"What helps and hinders metformin adherence and persistence? A qualitative study exploring the views of people with type 2 diabetes","volume":"134","author":"Parkin","year":"2021","journal-title":"N Z Med J"},{"key":"10.1016\/j.rcsop.2023.100385_bb0145","series-title":"Proceedings of the 18th European Conference on Research Methodology for Business and Management Studies","doi-asserted-by":"crossref","first-page":"92","DOI":"10.34190\/RM.19.075","article-title":"Student Experience of the Maximum Variation Framework for Determining Sample Size in Qualitative Research","author":"Daniel","year":"2019"},{"key":"10.1016\/j.rcsop.2023.100385_bb0150","series-title":"Introducing Qualitative Research in Psychology Berkshire","author":"Willig","year":"2013"},{"issue":"26","key":"10.1016\/j.rcsop.2023.100385_bb0155","article-title":"What about N? A methodological study of sample-size reporting in focus group studies","volume":"11","author":"Carlsen","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100385_bb0160","first-page":"256","article-title":"Focus group discussion: a tool for health and medical research","volume":"49","author":"Wong","year":"2008","journal-title":"Singap Med J"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100385_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.rcsop.2023.100385_bb0170","series-title":"Successful Qualitative Research: A Practical Guide for Beginners","author":"Clarke","year":"2013"},{"key":"10.1016\/j.rcsop.2023.100385_bb0175","author":"National Institute for Health and Care Excellence (NICE)"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100385_bb0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100385_bb0185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pec.2011.04.011","article-title":"Accepting the unacceptable: medication adherence and different types of action patterns among patients with high blood pressure","volume":"85","author":"Marx","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100385_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100385_bb0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11096-009-9361-5","article-title":"\u201cIt\u2019s just routine.\u201d a qualitative study of medicine-taking amongst older people in New Zealand","volume":"32","author":"Tordoff","year":"2010","journal-title":"Pharm World Sci"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100385_bb0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2524.2010.00951.x","article-title":"Treatment adherence in paediatric inflammatory bowel disease: perceptions from adolescent patients and their families","volume":"19","author":"Hommel","year":"2011","journal-title":"Health Soc Care Commun"},{"key":"10.1016\/j.rcsop.2023.100385_bb0205","author":"IBD Passport"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100385_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0145721715619038","article-title":"Medication adherence with diabetes medication: a systematic review of the literature","volume":"42","author":"Capoccia","year":"2016","journal-title":"Diabetes Educ"},{"issue":"23","key":"10.1016\/j.rcsop.2023.100385_bb0215","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.rcsop.2023.100385_bb0220","series-title":"Guidelines for Tuberculosis Control in New Zealand","first-page":"2019","author":"Ministry of Health","year":"2019"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100385_bb0225","first-page":"309","article-title":"Barriers to Mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis","volume":"20","author":"Devlen","year":"2014","journal-title":"J Manag Care Specialty Pharm"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100385_bb0230","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11096-018-0606-z","article-title":"The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes","volume":"40","author":"Kharjul","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"10.1016\/j.rcsop.2023.100385_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220116","article-title":"Helping patients help themselves: a systematic review of self-management support strategies in primary health care practice","volume":"14","author":"Dineen-Griffin","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rcsop.2023.100385_bb0240","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2147\/PPA.S84546","article-title":"Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens","volume":"9","author":"Lambert-Kerzner","year":"2015","journal-title":"Patient Prefer Adherence"},{"issue":"21\u221222","key":"10.1016\/j.rcsop.2023.100385_bb0245","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/jocn.13740","article-title":"Health care as perceived by persons with inflammatory bowel disease - a focus group study","volume":"26","author":"Lesnovska","year":"2017","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.rcsop.2023.100385_bb0250","author":"Ministry of Health"},{"key":"10.1016\/j.rcsop.2023.100385_bb0255","author":"National Health Service (NHS)"},{"key":"10.1016\/j.rcsop.2023.100385_bb0260","series-title":"The ASCRS Textbook of Colon and Rectal Surgery","first-page":"869","article-title":"Ulcerative colitis: Surgical management","author":"Krane","year":"2016"},{"key":"10.1016\/j.rcsop.2023.100385_bb0265","author":"National Institute for Health and Care Excellence (NICE)"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662300166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662300166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:07:25Z","timestamp":1762643245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266727662300166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":53,"alternative-id":["S266727662300166X"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100385","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cIt's just like putting your socks on\u201d: patients' perspectives on inflammatory bowel disease medication adherence","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100385"}}